The Lancet Hiv January 2019 Volume 6 Issue 1 Pages E1 E66
The Lancet Hiv January 2019 Volume 6 Issue 1 Pages E1 E66 The lancet hiv; the lancet infectious diseases; volume 6 number 1 e1 e66. kouzou sakai. current issue; online first; close. download full issue. download started. ok. The lancet hiv. 19.9 citescore. 12.8 impact factor. articles & issues. about. publish. volume 6, issue 1 pages e1 e66 (january 2019) download full issue. previous.
The Lancet Hiv November 2019 Volume 6 Issue 11 Pages E723 E806 The lancet hiv; the lancet infectious diseases; volume 8 number 1 e1 e58. hazem asif. on behalf of the sunnylands 2019 working group; open access. The lancet hiv; the lancet infectious diseases; jan 2019. volume 7 number 1 e1 e159. open access. pius mahimbi. Volume 6, issue 1 pages 1 80, e1 e3 (january 2019) download full issue. previous vol issue. correction to lancet psychiatry 2018;. The lancet hiv; the lancet infectious diseases; jan 2019. volume 6 number 1 p1 80, e1 e3. laura fischer. current issue;.
The Lancet Hiv April 2015 Volume 2 Issue 4 Pages E115 E168 Volume 6, issue 1 pages 1 80, e1 e3 (january 2019) download full issue. previous vol issue. correction to lancet psychiatry 2018;. The lancet hiv; the lancet infectious diseases; jan 2019. volume 6 number 1 p1 80, e1 e3. laura fischer. current issue;. Background: the integrase inhibitor dolutegravir could have a major role in future antiretroviral therapy (art) regimens in sub saharan africa because of its high potency and barrier to resistance, good tolerability, and low cost, but there is uncertainty over appropriate policies for use relating to the potential for drug resistance spread and a possible increased risk of neural tube defects. Survival by sex and hiv status in patients with anal cancer in the usa between 2001 and 2019: a retrospective cohort study. jaimie z shing, eric a engels, april a austin, megan a clarke, meredith s shiels. pages e31 e41. view pdf.
The Lancet Hiv August 2023 Volume 10 Issue 8 Pages E485 E556 Background: the integrase inhibitor dolutegravir could have a major role in future antiretroviral therapy (art) regimens in sub saharan africa because of its high potency and barrier to resistance, good tolerability, and low cost, but there is uncertainty over appropriate policies for use relating to the potential for drug resistance spread and a possible increased risk of neural tube defects. Survival by sex and hiv status in patients with anal cancer in the usa between 2001 and 2019: a retrospective cohort study. jaimie z shing, eric a engels, april a austin, megan a clarke, meredith s shiels. pages e31 e41. view pdf.
Comments are closed.